{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:02:10Z","timestamp":1794571330326,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Eugene R. Mindell and Harold Brody Clinical Translational Research Award"},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &amp; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K08HL130594"],"award-info":[{"award-number":["K08HL130594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","award":["IK2BX004097"],"award-info":[{"award-number":["IK2BX004097"]}],"id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Injury to the heart results in cardiomyocyte cell death and can lead to pathological remodeling of remaining cells, contributing to heart failure. Despite the therapeutic potential of new drugs and small molecules, there remains a gap in the ability to efficiently deliver cardioprotective agents in a cell specific manner while minimizing nonspecific delivery to other organs. Exosomes derived from cardiosphere-derived cells (CDCs) have been shown to stimulate angiogenesis, induce endogenous cardiomyocyte proliferation and modulate cardiomyocyte apoptosis and hypertrophy. While innately cardioprotective at high doses, unmodified CDC-exosomes demonstrate limited cardiac tropism. To generate an efficient exosomal delivery system that can target cardiomyocytes, we engineered CDCs to express Lamp2b, an exosomal membrane protein, fused to a cardiomyocyte specific peptide (CMP), WLSEAGPVVTVRALRGTGSW. Exosomes isolated from engineered CDCs expressed CMP on their surface and retained their native physical properties. Targeted exosomes resulted in increased uptake by cardiomyocytes, decreased cardiomyocyte apoptosis, and higher cardiac retention following intramyocardial injection when compared with non-targeted exosomes. Importantly, we established a novel targeting system to improve exosomal uptake by cardiomyocytes and laid the foundation for cell-specific exosomal delivery of drug and gene therapies to improve the functional capacity of the heart following both ischemic and non-ischemic injury.<\/jats:p>","DOI":"10.1038\/s41598-019-46407-1","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T09:50:39Z","timestamp":1562838639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":235,"title":["Exosomes Engineered to Express a Cardiomyocyte Binding Peptide Demonstrate Improved Cardiac Retention in Vivo"],"prefix":"10.1038","volume":"9","author":[{"given":"Kyle I.","family":"Mentkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6221-8625","authenticated-orcid":false,"given":"Jennifer K.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"key":"46407_CR1","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa1406656","volume":"372","author":"GA Roth","year":"2015","unstructured":"Roth, G. A. et al. Demographic and epidemiologic drivers of global cardiovascular mortality. The New England journal of medicine 372, 1333\u20131341, https:\/\/doi.org\/10.1056\/NEJMoa1406656 (2015).","journal-title":"The New England journal of medicine"},{"key":"46407_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.130","volume":"2","author":"M Chiong","year":"2011","unstructured":"Chiong, M. et al. Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis 2, e244, https:\/\/doi.org\/10.1038\/cddis.2011.130 (2011).","journal-title":"Cell Death Dis"},{"key":"46407_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1073\/pnas.1523918113","volume":"113","author":"KJ Carroll","year":"2016","unstructured":"Carroll, K. J. et al. A mouse model for adult cardiac-specific gene deletion with CRISPR\/Cas9. Proceedings of the National Academy of Sciences 113, 338\u2013343, https:\/\/doi.org\/10.1073\/pnas.1523918113 (2016).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"46407_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1208\/s12248-018-0211-z","volume":"20","author":"KI Mentkowski","year":"2018","unstructured":"Mentkowski, K. I., Snitzer, J. D., Rusnak, S. & Lang, J. K. Therapeutic Potential of Engineered Extracellular Vesicles. AAPS J 20, 50, https:\/\/doi.org\/10.1208\/s12248-018-0211-z (2018).","journal-title":"AAPS J"},{"key":"46407_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","volume":"2","author":"AG Ibrahim","year":"2014","unstructured":"Ibrahim, A. G., Cheng, K. & Marban, E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem cell reports 2, 606\u2013619, https:\/\/doi.org\/10.1016\/j.stemcr.2014.04.006 (2014).","journal-title":"Stem cell reports"},{"key":"46407_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/eurheartj\/ehw240","volume":"38","author":"R Gallet","year":"2017","unstructured":"Gallet, R. et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. European heart journal 38, 201\u2013211, https:\/\/doi.org\/10.1093\/eurheartj\/ehw240 (2017).","journal-title":"European heart journal"},{"key":"46407_CR7","doi-asserted-by":"publisher","first-page":"e0165926","DOI":"10.1371\/journal.pone.0165926","volume":"11","author":"JK Lang","year":"2016","unstructured":"Lang, J. K., Young, R. F., Ashraf, H. & Canty, J. M. Jr. Inhibiting Extracellular Vesicle Release from Human Cardiosphere Derived Cells with Lentiviral Knockdown of nSMase2 Differentially Effects Proliferation and Apoptosis in Cardiomyocytes, Fibroblasts and Endothelial Cells In Vitro. PloS one 11, e0165926, https:\/\/doi.org\/10.1371\/journal.pone.0165926 (2016).","journal-title":"PloS one"},{"key":"46407_CR8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/circresaha.115.306850","volume":"117","author":"BR Weil","year":"2015","unstructured":"Weil, B. R., Suzuki, G., Leiker, M. M., Fallavollita, J. A. & Canty, J. M. Jr Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium. Circ Res 117, 634\u2013644, https:\/\/doi.org\/10.1161\/circresaha.115.306850 (2015).","journal-title":"Circ Res"},{"key":"46407_CR9","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1182\/blood-2008-08-174094","volume":"113","author":"EN Nolte-\u2032t Hoen","year":"2009","unstructured":"Nolte-\u2032t Hoen, E. N., Buschow, S. I., Anderton, S. M., Stoorvogel, W. & Wauben, M. H. Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood 113, 1977\u20131981, https:\/\/doi.org\/10.1182\/blood-2008-08-174094 (2009).","journal-title":"Blood"},{"key":"46407_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jmb.2004.06.029","volume":"342","author":"MJ McGuire","year":"2004","unstructured":"McGuire, M. J., Samli, K. N., Johnston, S. A. & Brown, K. C. In vitro selection of a peptide with high selectivity for cardiomyocytes in vivo. J Mol Biol 342, 171\u2013182, https:\/\/doi.org\/10.1016\/j.jmb.2004.06.029 (2004).","journal-title":"J Mol Biol"},{"key":"46407_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29, 341\u2013345, https:\/\/doi.org\/10.1038\/nbt.1807 (2011).","journal-title":"Nat Biotechnol"},{"key":"46407_CR12","doi-asserted-by":"publisher","first-page":"26316","DOI":"10.3402\/jev.v4.26316","volume":"4","author":"OP Wiklander","year":"2015","unstructured":"Wiklander, O. P. et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. Journal of extracellular vesicles 4, 26316, https:\/\/doi.org\/10.3402\/jev.v4.26316 (2015).","journal-title":"Journal of extracellular vesicles"},{"key":"46407_CR13","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.xphs.2017.02.030","volume":"106","author":"M Morishita","year":"2017","unstructured":"Morishita, M., Takahashi, Y., Nishikawa, M. & Takakura, Y. Pharmacokinetics of Exosomes-An Important Factor for Elucidating the Biological Roles of Exosomes and for the Development of Exosome-Based Therapeutics. Journal of pharmaceutical sciences 106, 2265\u20132269, https:\/\/doi.org\/10.1016\/j.xphs.2017.02.030 (2017).","journal-title":"Journal of pharmaceutical sciences"},{"key":"46407_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ejps.2016.10.009","volume":"96","author":"C Charoenviriyakul","year":"2017","unstructured":"Charoenviriyakul, C. et al. Cell type-specific and common characteristics of exosomes derived from mouse cell lines: Yield, physicochemical properties, and pharmacokinetics. Eur J Pharm Sci 96, 316\u2013322, https:\/\/doi.org\/10.1016\/j.ejps.2016.10.009 (2017).","journal-title":"Eur J Pharm Sci"},{"key":"46407_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.xphs.2016.07.022","volume":"106","author":"A Matsumoto","year":"2017","unstructured":"Matsumoto, A. et al. Role of Phosphatidylserine-Derived Negative Surface Charges in the Recognition and Uptake of Intravenously Injected B16BL6-Derived Exosomes by Macrophages. Journal of pharmaceutical sciences 106, 168\u2013175, https:\/\/doi.org\/10.1016\/j.xphs.2016.07.022 (2017).","journal-title":"Journal of pharmaceutical sciences"},{"key":"46407_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.biomaterials.2016.07.003","volume":"105","author":"DC Watson","year":"2016","unstructured":"Watson, D. C. et al. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials 105, 195\u2013205, https:\/\/doi.org\/10.1016\/j.biomaterials.2016.07.003 (2016).","journal-title":"Biomaterials"},{"key":"46407_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/1074248411405990","volume":"16","author":"RA Kloner","year":"2011","unstructured":"Kloner, R. A. No-reflow phenomenon: maintaining vascular integrity. J Cardiovasc Pharmacol Ther 16, 244\u2013250, https:\/\/doi.org\/10.1177\/1074248411405990 (2011).","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"46407_CR18","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.biocel.2012.06.018","volume":"44","author":"S Rana","year":"2012","unstructured":"Rana, S., Yue, S., Stadel, D. & Zoller, M. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. The international journal of biochemistry & cell biology 44, 1574\u20131584, https:\/\/doi.org\/10.1016\/j.biocel.2012.06.018 (2012).","journal-title":"The international journal of biochemistry & cell biology"},{"key":"46407_CR19","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.7150\/thno.17092","volume":"7","author":"D Bellavia","year":"2017","unstructured":"Bellavia, D. et al. Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth. Theranostics 7, 1333\u20131345, https:\/\/doi.org\/10.7150\/thno.17092 (2017).","journal-title":"Theranostics"},{"key":"46407_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/10717544.2016.1253121","volume":"24","author":"X Wang","year":"2017","unstructured":"Wang, X., Huang, H., Zhang, L., Bai, Y. & Chen, H. PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations. Drug Delivery 24, 339\u2013345, https:\/\/doi.org\/10.1080\/10717544.2016.1253121 (2017).","journal-title":"Drug Delivery"},{"key":"46407_CR21","doi-asserted-by":"publisher","first-page":"8081","DOI":"10.1016\/j.biomaterials.2010.07.025","volume":"31","author":"HY Nam","year":"2010","unstructured":"Nam, H. Y., McGinn, A., Kim, P.-H., Kim, S. W. & Bull, D. A. Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials 31, 8081\u20138087, https:\/\/doi.org\/10.1016\/j.biomaterials.2010.07.025 (2010).","journal-title":"Biomaterials"},{"key":"46407_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1567201043480063","volume":"1","author":"L Wei","year":"2004","unstructured":"Wei, L., Tatyana, L., Ban-An, K. & Vladimir, T. ATP-Containing Immunoliposomes Specific for Cardiac Myosin. Current. Drug Delivery 1, 1\u20137, https:\/\/doi.org\/10.2174\/1567201043480063 (2004).","journal-title":"Drug Delivery"},{"key":"46407_CR23","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1016\/j.biomaterials.2013.12.099","volume":"35","author":"M Liu","year":"2014","unstructured":"Liu, M. et al. The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy. Biomaterials 35, 3697\u20133707, https:\/\/doi.org\/10.1016\/j.biomaterials.2013.12.099 (2014).","journal-title":"Biomaterials"},{"key":"46407_CR24","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1096\/fj.08-127373","volume":"23","author":"RC Scott","year":"2009","unstructured":"Scott, R. C. et al. Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. The FASEB Journal 23, 3361\u20133367, https:\/\/doi.org\/10.1096\/fj.08-127373 (2009).","journal-title":"The FASEB Journal"},{"key":"46407_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.yjmcc.2011.02.003","volume":"50","author":"S Kanki","year":"2011","unstructured":"Kanki, S. et al. Identification of targeting peptides for ischemic myocardium by in vivo phage display. Journal of Molecular and Cellular Cardiology 50, 841\u2013848, https:\/\/doi.org\/10.1016\/j.yjmcc.2011.02.003 (2011).","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"46407_CR26","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.7150\/thno.20524","volume":"8","author":"A Vandergriff","year":"2018","unstructured":"Vandergriff, A. et al. Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. Theranostics 8, 1869\u20131878, https:\/\/doi.org\/10.7150\/thno.20524 (2018).","journal-title":"Theranostics"},{"key":"46407_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.bbrc.2018.03.227","volume":"499","author":"H Kim","year":"2018","unstructured":"Kim, H. et al. Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes. Biochemical and Biophysical Research Communications 499, 803\u2013808, https:\/\/doi.org\/10.1016\/j.bbrc.2018.03.227 (2018).","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"46407_CR28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/jemt.22397","volume":"77","author":"M Gao","year":"2014","unstructured":"Gao, M. et al. Direct observation of liquid crystals using cryo-TEM: Specimen preparation and low-dose imaging. Microscopy Research and Technique 77, 754\u2013772, https:\/\/doi.org\/10.1002\/jemt.22397 (2014).","journal-title":"Microscopy Research and Technique"},{"key":"46407_CR29","doi-asserted-by":"crossref","unstructured":"Cavalier, A., Spehner, Daniele, Humbel, Bruno, M. In Handbook of Cryo-Preparation Methods for Electron Microscopy 69 (CRC Press, 2008).","DOI":"10.1201\/9780367800833"},{"key":"46407_CR30","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/ar.22641","volume":"296","author":"EC Jensen","year":"2013","unstructured":"Jensen, E. C. Quantitative analysis of histological staining and fluorescence using Image. J. Anat Rec (Hoboken) 296, 378\u2013381, https:\/\/doi.org\/10.1002\/ar.22641 (2013).","journal-title":"J. Anat Rec (Hoboken)"},{"key":"46407_CR31","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/circresaha.116.305462","volume":"116","author":"SP Jones","year":"2015","unstructured":"Jones, S. P. et al. The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs. Circ Res 116, 572\u2013586, https:\/\/doi.org\/10.1161\/circresaha.116.305462 (2015).","journal-title":"Circ Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46407-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46407-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46407-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:18:37Z","timestamp":1671257917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46407-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["46407"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-46407-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]},"assertion":[{"value":"21 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10041"}}